samedan logo
 
 
spacer
home > pmps > winter 2017 > innovative manufacturing technologies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Innovative Manufacturing Technologies

Since the mid-2000s, the pre-filled syringe market has grown rapidly. An increasing number of drugs have been developed and presented in a subcutaneously injectable format because of the significant benefits in comparison to traditional glass primary packaging, such as vials or ampoules. This trend is fuelled by an ageing population and, as the number of chronic disease sufferers increases, so do therapies.

Pre-filled syringes – particularly when used with auto-injectors – enable people with lifelong conditions to safely and conveniently self-administer their medications, thus improving their quality of life and treatment compliance. This also positively contributes to decreasing overall healthcare costs by shifting patient care from hospitals to the home.

Ready-to-use (RTU) sterile syringes account for approximately 80% of the global consumption of these primary containers. The remaining 20% are bulk ones which still need to be washed, siliconised, assembled and sterilised before they can be processed on a fill and finish line. Although there are still firms sourcing the latter, there is a clear trend toward switching to RTU syringes and, therefore, outsourcing operations to primary packaging suppliers.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Philippe Lauwers is Business Unit Director Pre-Filled Syringes at Nipro PharmaPackaging, a division of Nipro Corporation. He graduated in Biotechnology from the Ghent University, Belgium, and worked as a scientific researcher at the Catholic University of Leuven, Belgium. Upon obtaining an additional degree in Biomedical Engineering, Philippe moved from an academic to an industrial environment. He has been active in the medical and pharma packaging sector for the last 10 years in various roles.

Matteo Falgari is Business Development Manager of Pre-Fillable Syringes at Nipro PharmaPackaging. Matteo joined the company in October 2015 and is responsible for business development initiatives for their pre-fillable glass syringe systems across Europe, the Middle East and Africa. He graduated in Industrial Engineering from the University of Bergamo, Italy, in 2012 and has been active in the pharma primary packaging field with growing responsibilities in various sales and business development roles since then.
spacer
Philippe Lauwers
spacer
spacer
spacer
Matteo Falgari
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Lesaffre Acquires Recombia Biosciences, a Biotechnology Company Specialized in High-Throughput Genome Editing and Synthetic Biology

Lesaffre, a global key player in the field of fermentation for nearly 170 years, today announces the acquisition of Recombia Biosciences, a biotechnology company based in the San Francisco Bay Area and founded in 2019 based on technology licensed from Stanford University. This acquisition is the culmination of a strategic partnership initiated in 2020 to leverage Recombia Biosciences’ genome-editing technologies and accelerate the development of yeasts for sustainable production of fermented ingredients. The partnership marked Lesaffre’s entry into the world of Synthetic Biology, considered to be one of the largest biotechnology opportunities of this decade.
More info >>

White Papers
 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement